These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28207279)

  • 1. Angiotensin-Converting Inhibitors and Angiotensin II Receptor Blockers and Longitudinal Change in Percent Emphysema on Computed Tomography. The Multi-Ethnic Study of Atherosclerosis Lung Study.
    Parikh MA; Aaron CP; Hoffman EA; Schwartz JE; Madrigano J; Austin JHM; Kalhan R; Lovasi G; Watson K; Stukovsky KH; Barr RG
    Ann Am Thorac Soc; 2017 May; 14(5):649-658. PubMed ID: 28207279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.
    Tejwani V; Fawzy A; Putcha N; Castaldi PJ; Cho MH; Pratte KA; Bhatt SP; Lynch DA; Humphries SM; Kinney GL; D'Alessio FR; Hansel NN;
    Chest; 2021 Oct; 160(4):1245-1254. PubMed ID: 34029566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Longitudinal Cohort Study of Aspirin Use and Progression of Emphysema-like Lung Characteristics on CT Imaging: The MESA Lung Study.
    Aaron CP; Schwartz JE; Hoffman EA; Angelini E; Austin JHM; Cushman M; Jacobs DR; Kaufman JD; Laine A; Smith LJ; Yang J; Watson KE; Tracy RP; Barr RG
    Chest; 2018 Jul; 154(1):41-50. PubMed ID: 29246770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
    Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
    J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.
    Rosen AB; Karter AJ; Liu JY; Selby JV; Schneider EC
    J Gen Intern Med; 2004 Jun; 19(6):669-75. PubMed ID: 15209606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV; Dass EE
    Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
    Coleman CI; Makanji S; Kluger J; White CM
    Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study.
    Pistenmaa CL; Nardelli P; Ash SY; Come CE; Diaz AA; Rahaghi FN; Barr RG; Young KA; Kinney GL; Simmons JP; Wade RC; Wells JM; Hokanson JE; Washko GR; San José Estépar R;
    Chest; 2021 Aug; 160(2):470-480. PubMed ID: 33607083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial.
    Düsing R; Sellers F
    Curr Med Res Opin; 2009 Sep; 25(9):2287-301. PubMed ID: 19635044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary artery stiffness in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.
    Liu CY; Parikh M; Bluemke DA; Balte P; Carr J; Dashnaw S; Poor HD; Gomes AS; Hoffman EA; Kawut SM; Lima JAC; McAllister DA; Prince MA; Vogel-Claussen J; Barr RG
    J Magn Reson Imaging; 2018 Jan; 47(1):262-271. PubMed ID: 28488348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
    Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percent Emphysema and Daily Motor Activity Levels in the General Population: Multi-Ethnic Study of Atherosclerosis.
    Lo Cascio CM; Quante M; Hoffman EA; Bertoni AG; Aaron CP; Schwartz JE; Avdalovic MV; Fan VS; Lovasi GS; Kawut SM; Austin JHM; Redline S; Barr RG
    Chest; 2017 May; 151(5):1039-1050. PubMed ID: 27940190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization.
    Cooke CE; Fatodu H
    J Manag Care Pharm; 2006 Oct; 12(8):649-55. PubMed ID: 17269843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients prescribed angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or the combination at an urban medical center.
    Masri G; Bledsoe K; Palacio C
    MedGenMed; 2007 Nov; 9(4):40. PubMed ID: 18311390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule 1 and progression of percent emphysema: the MESA Lung Study.
    Aaron CP; Schwartz JE; Bielinski SJ; Hoffman EA; Austin JH; Oelsner EC; Donohue KM; Kalhan R; Berardi C; Kaufman JD; Jacobs DR; Tracy RP; Barr RG
    Respir Med; 2015 Feb; 109(2):255-64. PubMed ID: 25457724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
    Pai PY; Muo CH; Sung FC; Ho HC; Lee YT
    Int J Cardiol; 2016 Jul; 215():114-9. PubMed ID: 27111172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary
    Lessard E; Young HM; Bhalla A; Pike D; Sheikh K; McCormack DG; Ouriadov A; Parraga G
    Acad Radiol; 2017 Nov; 24(11):1402-1411. PubMed ID: 28645458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study.
    Oelsner EC; Hoffman EA; Folsom AR; Carr JJ; Enright PL; Kawut SM; Kronmal R; Lederer D; Lima JA; Lovasi GS; Shea S; Barr RG
    Ann Intern Med; 2014 Dec; 161(12):863-73. PubMed ID: 25506855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.